[go: up one dir, main page]

YU40997A - Novi oksadiazoli, postupci za njihovo pripremanje - Google Patents

Novi oksadiazoli, postupci za njihovo pripremanje

Info

Publication number
YU40997A
YU40997A YU40997A YU40997A YU40997A YU 40997 A YU40997 A YU 40997A YU 40997 A YU40997 A YU 40997A YU 40997 A YU40997 A YU 40997A YU 40997 A YU40997 A YU 40997A
Authority
YU
Yugoslavia
Prior art keywords
processes
preparation
oxadiazoles
new
general formula
Prior art date
Application number
YU40997A
Other languages
English (en)
Inventor
Michael Brenner
Roland Maier
Marion Wienrich
Thomas Weiser
Rainer Palluk
Wolf-Dietrich Bechtel
Angelo Sagrada
Helmut Ensinger
Uwe Pschorn
Raffaele Cesana
Original Assignee
Boehringer Ingelheim Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg. filed Critical Boehringer Ingelheim Kg.
Publication of YU40997A publication Critical patent/YU40997A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Pronalazak se odnosi na derivate oksadiazola, opšte formule (I) pri čemu su X, Y, Z i R1 definisani kao što je izneto u opisu i u patentnim zahtevima, i na postupke za njihovo pripremanje.
YU40997A 1996-10-18 1997-10-16 Novi oksadiazoli, postupci za njihovo pripremanje YU40997A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19643037A DE19643037A1 (de) 1996-10-18 1996-10-18 Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
YU40997A true YU40997A (sh) 2000-10-30

Family

ID=7809114

Family Applications (1)

Application Number Title Priority Date Filing Date
YU40997A YU40997A (sh) 1996-10-18 1997-10-16 Novi oksadiazoli, postupci za njihovo pripremanje

Country Status (31)

Country Link
US (1) US6277872B1 (sh)
EP (1) EP0934288B1 (sh)
JP (1) JP3333523B2 (sh)
KR (1) KR20000049253A (sh)
CN (1) CN1086698C (sh)
AR (1) AR008496A1 (sh)
AT (1) ATE315034T1 (sh)
AU (1) AU737552B2 (sh)
BG (1) BG103251A (sh)
BR (1) BR9714354A (sh)
CA (1) CA2268954C (sh)
CO (1) CO4920253A1 (sh)
CZ (1) CZ138099A3 (sh)
DE (2) DE19643037A1 (sh)
EE (1) EE9900147A (sh)
ES (1) ES2256880T3 (sh)
HR (1) HRP970553A2 (sh)
HU (1) HUP0001652A3 (sh)
ID (1) ID18613A (sh)
IL (1) IL129315A0 (sh)
NO (1) NO312512B1 (sh)
NZ (1) NZ335598A (sh)
PE (1) PE11199A1 (sh)
PL (1) PL332432A1 (sh)
RU (1) RU2182905C2 (sh)
SK (1) SK49999A3 (sh)
TR (1) TR199900848T2 (sh)
TW (1) TW413678B (sh)
WO (1) WO1998017652A1 (sh)
YU (1) YU40997A (sh)
ZA (1) ZA979220B (sh)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1300055B1 (it) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
IT1300056B1 (it) 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
DE60027546T2 (de) 1999-02-15 2007-04-26 Eisai Co., Ltd. Heterodiazinon-derivate
ES2211420T3 (es) * 1999-07-21 2004-07-16 F. Hoffmann-La Roche Ag Derivados de triazol.
US6660753B2 (en) 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
EP1582519A3 (en) * 1999-08-19 2005-12-21 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
EP1210344B1 (en) * 1999-08-19 2005-10-19 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US6579880B2 (en) * 2000-06-06 2003-06-17 Ortho-Mcneil Pharmaceutical, Inc. Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8
EP1300396B1 (en) 2000-06-12 2009-01-14 Eisai R&D Management Co., Ltd. 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
EP1319659B1 (en) * 2000-09-18 2009-03-11 Eisai R&D Management Co., Ltd. Triazinones and medicinal use thereof
ATE375340T1 (de) * 2001-02-21 2007-10-15 Nps Pharma Inc Heteropolycyclische verbindungen und deren verwendung als metabotrope glutamatrezeptorantagonisten
JP4303109B2 (ja) * 2001-10-04 2009-07-29 メルク エンド カムパニー インコーポレーテッド 代謝共役型グルタミン酸受容体−５のヘテロアリール置換テトラゾール調節剤
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
CA2494987C (en) * 2002-08-09 2012-04-17 Astrazeneca Ab Isoxazoles and their use as modulators of metabotropic glutamate receptor-5
DE10240818A1 (de) * 2002-08-30 2004-05-13 Grünenthal GmbH Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate
KR20050033653A (ko) 2002-08-23 2005-04-12 리겔 파마슈티칼스, 인크. Ｈｃｖ 감염의 치료 또는 예방에 유용한 피리딜 치환 헤테로사이클
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
RU2338746C2 (ru) * 2003-02-27 2008-11-20 НьюроСёрч А/С Новые диазабициклические арильные производные, содержащие их фармацевтические композиции и их применение
EP1620412A2 (en) 2003-05-02 2006-02-01 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US7115642B2 (en) 2003-05-02 2006-10-03 Rigel Pharmaceuticals, Inc. Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection
US7220745B2 (en) 2003-05-15 2007-05-22 Rigel Pharmaceuticals Heterocyclic compounds useful to treat HCV
WO2005049065A2 (en) 2003-11-19 2005-06-02 Rigel Pharmaceuticals, Inc. Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections
JP4958560B2 (ja) * 2003-12-24 2012-06-20 プロシディオン・リミテッド Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
CN101180056A (zh) * 2005-04-08 2008-05-14 卫材R&D管理有限公司 运动障碍治疗剂
JP2008540425A (ja) 2005-05-02 2008-11-20 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝可能部分を含む複素環式抗ウイルス性化合物およびその使用
GB0510142D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
HUP0500920A2 (en) * 2005-10-05 2007-07-30 Richter Gedeon Nyrt Oxadiazole derivatives, process for their preparation and their use
DE102005061427A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxadiazol-Derivate
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
BRPI0720043A2 (pt) * 2006-12-15 2014-01-07 Abbott Lab Composto oxadiazol
US20110207704A1 (en) * 2006-12-15 2011-08-25 Abbott Laboratories Novel Oxadiazole Compounds
JO2701B1 (en) 2006-12-21 2013-03-03 جلاكسو جروب ليميتد Vehicles
WO2009043890A1 (en) * 2007-10-04 2009-04-09 Merck Serono S.A. Oxadiazole diaryl compounds
WO2009082398A1 (en) * 2007-12-21 2009-07-02 University Of Notre Dame Du Lac Antibacterial compounds and methods of using same
BRPI0913609B8 (pt) 2008-06-09 2021-05-25 Univ Muenchen Ludwig Maximilians composto para inibição de agregação de proteínas envolvidas em doenças ligadas à agregação de proteína e/ou doenças neurodegenerativas e em depósitos de imagem de proteína agregada, uso do mesmo, e kit
RU2398770C1 (ru) * 2009-03-27 2010-09-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Меченная тритием 3-[5-(2-фторфенил)-1,2,4-оксадиазол-3-ил]бензойная кислота
WO2011047129A1 (en) * 2009-10-15 2011-04-21 Southern Research Institute Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
RU2641293C2 (ru) * 2012-08-24 2018-01-17 Тревентис Корпорейшн Бензофуразановые антимилоидные соединения и способы
US9938249B2 (en) 2014-02-27 2018-04-10 Treventis Corporation Anti-amyloid compounds containing benzofurazan
CN106231905B (zh) 2014-04-24 2019-04-09 住友化学株式会社 二芳基-唑化合物
US10662164B2 (en) 2014-09-25 2020-05-26 University Of Notre Dame Du Lac Non-beta lactam antibiotics
CN107286174B (zh) * 2016-04-11 2020-08-18 上海勋和医药科技有限公司 取代2,4-(1h,3h)嘧啶二酮作为parp抑制剂及其应用
WO2018049404A1 (en) 2016-09-12 2018-03-15 University Of Notre Dame Du Lac Compounds for the treatment of clostridium difficile infection
US11180518B2 (en) 2017-05-12 2021-11-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma
US10676467B2 (en) 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof
MA54460A (fr) 2018-12-14 2021-10-20 Eisai R&D Man Co Ltd Formulations pharmaceutiques à base d'eau de composés de 1,2-dihydropyridine
JPWO2023042887A1 (sh) 2021-09-15 2023-03-23
EP4403185A4 (en) 2021-09-15 2025-10-08 Univ Of The Ryukyus PHARMACEUTICAL COMPOSITION INTENDED FOR USE IN THE TREATMENT OF EITHER THE DECLINE OF COGNITIVE FUNCTIONS OR OVERWEIGHT OR OBESITY
EP4173485A1 (en) 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003909A (en) * 1974-07-22 1977-01-18 E. R. Squibb & Sons, Inc. [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters
JPS52272A (en) * 1975-10-17 1977-01-05 Takeda Chem Ind Ltd Process for preparing 1,2,4-oxadiazole derivatives
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4871753A (en) * 1986-12-12 1989-10-03 Ciba-Geigy Corporation 3-Phenyl-5-trifluoromethyl-1,2,4-oxadiazole compounds which are useful pesticides
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
JPH02250873A (ja) * 1989-03-24 1990-10-08 Mitsubishi Petrochem Co Ltd １，２，４―オキサジアゾール誘導体及びそれを有効成分とする除草剤
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
WO1993002677A1 (en) * 1991-08-03 1993-02-18 Smithkline Beecham Plc 5-ht4 receptor antagonists
WO1994017048A1 (fr) * 1993-01-21 1994-08-04 Nippon Soda Co., Ltd. Derive d'oxadiazole
DE4401108A1 (de) * 1994-01-17 1995-07-20 Bayer Ag 1,2,4-Oxadiazol-Derivate
DE4401107A1 (de) * 1994-01-17 1995-07-20 Bayer Ag 3-Aryl-alkenyl-1,2,4-oxadiazol-Derivate
DE19528189A1 (de) * 1995-08-01 1997-02-06 Basf Ag Benzolderivate mit einem heterocyclischen Rest

Also Published As

Publication number Publication date
ES2256880T3 (es) 2006-07-16
BG103251A (bg) 2000-02-29
RU2182905C2 (ru) 2002-05-27
HUP0001652A3 (en) 2002-12-28
AU4867697A (en) 1998-05-15
AR008496A1 (es) 2000-01-19
HK1020956A1 (en) 2000-05-26
JP2000505089A (ja) 2000-04-25
HRP970553A2 (en) 1998-08-31
DE19643037A1 (de) 1998-04-23
EE9900147A (et) 1999-12-15
CO4920253A1 (es) 2000-05-29
EP0934288B1 (de) 2006-01-04
NO312512B1 (no) 2002-05-21
HUP0001652A2 (hu) 2001-01-29
WO1998017652A1 (de) 1998-04-30
TR199900848T2 (xx) 1999-06-21
ID18613A (id) 1998-04-23
PL332432A1 (en) 1999-09-13
CN1233245A (zh) 1999-10-27
NO991815D0 (no) 1999-04-16
CA2268954C (en) 2006-06-13
TW413678B (en) 2000-12-01
JP3333523B2 (ja) 2002-10-15
PE11199A1 (es) 1999-03-03
IL129315A0 (en) 2000-02-17
BR9714354A (pt) 2000-04-11
KR20000049253A (ko) 2000-07-25
EP0934288A1 (de) 1999-08-11
DE59712543D1 (de) 2006-03-30
CZ138099A3 (cs) 1999-11-17
NZ335598A (en) 2001-06-29
AU737552B2 (en) 2001-08-23
ZA979220B (en) 1998-04-20
ATE315034T1 (de) 2006-02-15
CA2268954A1 (en) 1998-04-30
NO991815L (no) 1999-04-16
CN1086698C (zh) 2002-06-26
US6277872B1 (en) 2001-08-21
SK49999A3 (en) 1999-11-08

Similar Documents

Publication Publication Date Title
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
YU35697A (sh) Supstituisani 6,6-hetero-biciklični derivati
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
FI970246A7 (fi) Dihydrobentsofuraanit
YU4397A (sh) Novi supstituisani oksazolidinoni
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
BG92804A (bg) 4-бензоилизоксазолови производни
BG103485A (en) Ketobanzamides as calpain inhibitors
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
DK1200418T3 (da) Nematodicide trifluorbutener
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
ATE297903T1 (de) Substituierte phenyluracile
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
DE69330601D1 (de) Serotoninergische ergolin derivate
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK1178985T3 (da) Substituerede thienocycloalk(en)ylamino-1,3,5-triaziner